Skip to main content
. Author manuscript; available in PMC: 2010 Dec 31.
Published in final edited form as: J Immunol Methods. 2009 Sep 23;351(1-2):55–61. doi: 10.1016/j.jim.2009.09.004

Figure 2. Anti-Id levels measured in different assays.

Figure 2

Samples obtained from healthy matched controls (squares) and new-onset T1D patients (circles) were tested for the presence of GAD65Ab-specific anti-Id in b96.11-biotin/streptavidin assay (a), ECL (b), and b96.11-PAS assay (c). Anti-Id detected in absorption assays (a and c) are reported as the difference in GAD65Ab index after absorption as compared to the index before absorption. Anti-Id detected in ECL are reported as relative index. Median binding is indicated.